U.S. SC hears arguments in Teva patent case

Published October 15, 2014 6:00pm ET



WASHINGTON (Legal Newsline) – The U.S. Supreme Court must decide whether a district court’s factual finding in support of its patent claim construction may be reviewed de novo or only for clear error.

 

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.